
The withdrawal came on the eve of a Senate committee vote, leaving the FDA without a nominee as vaccine and mifepristone debates continue.
How can Generative AI might improve the health care retail space?
In part 1 of this interview, Deborah Weinswig, CEO and Founder of Coresight Research, sat down with Drug Topics to discuss the ways Generative AI might improve the health care retail space and the potential challenges around the increased use of Generative AI.






